SCHEDULE: Vanguard Reports Zero Beneficial Ownership in TransMedics

The Vanguard Group has filed an amendment to its Schedule 13G, reporting 0% beneficial ownership in TransMedics Group Inc. following an internal realignment.

Summary

• The Vanguard Group, Inc. filed an Amendment No. 3 to its Schedule 13G regarding TransMedics Group Inc. common stock.
• As of the event date, The Vanguard Group reported 0% beneficial ownership in TransMedics Group Inc.
• This change is due to an internal realignment at The Vanguard Group, Inc. on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The filing confirms that The Vanguard Group, including its managed accounts, retains the right to receive or direct dividends and proceeds from the securities, but no single other person's interest exceeds 5%.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative development for TransMedics Group Inc. While the reason for the 0% beneficial ownership is an internal Vanguard realignment, the optics of a major institutional investor reporting no stake can create uncertainty and potentially impact investor sentiment.

Negatives

• The Vanguard Group, a major institutional investor, now reports 0% beneficial ownership in TransMedics Group Inc., which could be perceived negatively by some investors despite the internal restructuring reason.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding TransMedics Group Inc.'s future performance or The Vanguard Group's investment strategy beyond the reporting change.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." Ashley Grim, Head of Global Fund Administration, The Vanguard Group.

Industry Context

StockSavvy.ai notes that internal realignments and disaggregated reporting by large asset managers like Vanguard are not uncommon. While the reported 0% beneficial ownership might initially appear as a divestment, the explanation clarifies it's a structural change in how Vanguard's various entities report their holdings, rather than a complete exit from the investment in TransMedics Group Inc. by all Vanguard-affiliated funds.

Stakeholder Impact

• Shareholders of TransMedics Group Inc. may react to the reported reduction in The Vanguard Group's beneficial ownership, potentially leading to short-term price volatility, even with the explanation of internal restructuring.

Key Dates

Recommendation

While The Vanguard Group's reported beneficial ownership in TransMedics Group Inc. has dropped to 0%, this is attributed to an internal realignment and disaggregated reporting, not a direct sell-off by all Vanguard-managed funds. The underlying investment may still exist across Vanguard's subsidiaries. Therefore, a 'hold' recommendation is appropriate as this filing alone does not indicate a fundamental change in TransMedics' business or a complete institutional exit, but rather a reporting adjustment. Investors should monitor future filings from Vanguard's disaggregated entities for a clearer picture of their collective stake.

Keywords

TransMedics Group Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, SEC Filing, Common Stock, Ownership Change